R/€ = 15.90 Change: -0.01
R/$ = 14.08 Change: 0.00
Au 1320.93 $/oz Change: 5.93
Pt 805.07 $/oz Change: 17.61


Worst-performing South African stock gets bid for crown jewel

By: Bloomberg     15th January 2019 Ascendis Health is in talks to sell one of its best-performing units as last year’s biggest South African loser on Johannesburg’s stock exchange battles to ensure survival. The debt-laden maker of multivitamins, probiotics and pet nutritional supplements received an unsolicited offer for Cyprian... 

Pharmaceutical giant Mylan acquires ARV drugs manufacturing plant in South Africa

By: African News Agency      8th January 2019 Global pharmaceutical company Mylan on Tuesday announced the acquisition of a manufacturing site, previously owned by Ascendis Health, for its plans to produce high-quality antiretrovirals for seven million South Africans living with HIV. Spread over an expanse of 2.34 ha, the facility at Isando... 

Mobile laboratories use robots to teach children about sciences 

4th October 2018 The Inspired towards Science, Engineering and Technology, or I-Set, project, sponsored by petrochemicals company Sasol and facilitated by the University of South Africa, uses mobile laboratories and robotics kits to teach science to school children. Schalk Burger has the story. 

Ascendis launches new strategic focus, announces positive FY18 results 

By: Nadine James     25th September 2018 JSE-listed pharmaceutical company Ascendis Health on Tuesday announced a new strategic focus prioritising pharmaceutical and consumer healthcare. The company, which also reported on its results for the financial year ended June 30, plans to divest its biosciences businesses. 

Go Life acquires Wellness Brands, other Ascendis Health assets

By: Marleny Arnoldi     3rd September 2018 JSE-listed Go Life International and its subsidiary Go Life Healthcare have entered into two agreements with Ascendis Health, to acquire the Wellness Brands – the Biobalance, Foodstate, Osteoflex and Homeoforce brands – and 100% of the shares and claims in Sportron, Heritage Resources, Ascendis... 

Ascendis to sell noncore assets in South Africa

By: Anine Kilian     25th June 2018 South African healthcare provider Ascendis Health plans to dispose of smaller local noncore businesses as part of a strategic review aimed at improving cash generation and enhancing profitability. Ascendis will sell its sports nutrition business, its direct selling and network marketing business... 

Ascendis Health lists on A2X

By: Marleny Arnoldi     29th May 2018 Multinational health and care brands company Ascendis Health on Tuesday became the first healthcare company to list on A2X, with a market capitalisation of R5.4-billion.  

Ascendis to get secondary listing on A2X

By: Simone Liedtke     22nd May 2018 Multinational healthcare company Ascendis Health will from May 29, also start trading on new exchange A2X. This follows the approval on Tuesday, in which the company was included in the list of qualifying equity securities. 

Ascendis launches strategic review, headline earnings increase to R535m in H1

By: Simone Liedtke     1st March 2018 Pharmaceutical company Ascendis Health has initiated a strategic business review to create a sustainable market position for itself and to accelerate organic growth following the completion of several acquisitions locally and offshore since the company's listing in 2013. The review is expected to... 

Ascendis looks to settle debt through rights offer

By: Megan van Wyngaardt     19th December 2017 Ascendis Health is aiming to raise R750-million through a fully underwritten renounceable rights offer. The proceeds will be used to settle 50-million of the deferred vendor consideration payment owed to the sellers of Remedica Holdings, an international pharmaceutical business acquired in 2016,... 

Ascendis, Remedica Holdings settlement reduced

By: Anine Kilian     13th November 2017 JSE-listed multinational health and care company Ascendis Health has amended the repayment terms for its R4.4-billion acquisition of Cyprus-based Remedica Holdings, reducing the deferred payment from €90-million to €86.2-million. The company announced in May 2016 that it would acquire the entire... 

Ascendis notes growth through acquisitions, will remain acquisitive

By: Megan van Wyngaardt     8th March 2017 Health and care brands group Ascendis Health increased its revenue by 66% to R3.1-billion in the half year to December 31, as the business significantly increased international sales following two major acquisitions in Europe. This included the acquisitions of Cyprus-based pharmaceutical... 

Ascendis To Acquire Cipla Veterinary Business For R375 Million

7th March 2017 Ascendis Health, the high growth health and care brands group, is to purchase the southern African veterinary operations of Cipla India for R375 million. Cipla Vet (companion animals) and Cipla Agrimed (commercial animals) sell a range of high quality animal medicines. The business was... 

Ascendis buys Cipla’s Southern African veterinary operations for R375m

By: Anine Kilian     6th March 2017 Health and care brands group Ascendis Health, will acquire the Southern African veterinary operations of Cipla India for R375-million. The purchase price includes a deferred payment of R50-million over 15 months. The acquisition will take effect in April. 

Ascendis focuses on international growth

By: Megan van Wyngaardt     14th September 2016 Despite its results being impacted by offshore acquisitions and its headline earnings per share (HEPS) dropping 30% to 56c in the year ended June 30, health and care company Ascendis Health still reported a 41% increase to R613-million in normalised earnings before interest, taxes, depreciation... 

Ascendis Health acquires two European firms for R7.3bn

By: Creamer Media Reporter      24th May 2016 As part of its international growth strategy, JSE-listed Ascendis Health has acquired two major European health and care businesses, Remedica Holdings and Scitec International, for a combined R7.3-billion. “Our strategy is to complement growth in the domestic health and care market through... 

Ascendis Health Profits Up 66% As Offshore Expansion Gains Momentum

9th March 2016 Integrated health and care brands group, Ascendis Health, delivered continued strong profit growth of 66% to R147 million in the six months to December 2015. Headline earnings for the half year grew by 48% to R131 million, with headline earnings per share up 37% to 49 cents. An interim dividend... 

Ascendis acquires Akacia Healthcare in R345m deal

By: Megan van Wyngaardt     19th November 2015 JSE-listed health and care brands group Ascendis Health has inked a R345-million deal to acquire 100% of Akacia Healthcare’s pharmaceutical business, subject to regulatory and competition approvals.   Akacia manufactured and distributed branded generic prescription, over-the-counter and... 

Ascendis makes international foray with Spanish acquisition

By: Sashnee Moodley     21st August 2015 Health and care brands group Ascendis Health last week announced its first international acquisition – an initial 49% stake in Spanish pharmaceutical group Farmalider for R210-million. 

Ascendis makes first international acquisition with buy-out of Spanish group

By: Sashnee Moodley     3rd August 2015 Health and care brands group Ascendis Health on Monday announced its first international acquisition – an initial 49% stake in Spanish pharmaceutical group Farmalider for R210-million. 

Ascendis mulls further acquisitive growth opportunities

By: Sashnee Moodley     27th March 2015 Health and care brands group Ascendis Health reported a 101% year-on-year rise in revenue to R1.3-billion for the six months ended December 31. 

Ascendis reports revenue growth of 101%

By: Sashnee Moodley     12th March 2015 Health and care brands group Ascendis Health on Thursday reported a 101% year-on-year rise in revenue to R1.3-billion for the six months ended December 31. 

Ascendis acquires Scientific Group in R283m deal

By: Leandi Kolver     28th October 2014 Health and care group Ascendis Health has entered into an agreement to acquire the majority of the Scientific Group, including its diagnostics business SG Diagnostics, for a consideration of R283.7-million in cash and shares. The deal also included a minority interest in a medical business within... 

MIC attributes 2013 gains to investment diversification strategy

By: Natalie Greve     2nd July 2014 Emphasising that the Mineworkers Investment Company (MIC) would continue to be opportunistic if attractive investment opportunities arose, CEO Mary Bomela said on Wednesday that a 31% rise in the value of the group’s investment portfolio to R4.9-billion for the year to February 28 was a product... 

Ascendis Health announces R200m empowerment deal with MIC

By: Natalie Greve     27th June 2014 Ascendis Health, the third-largest pharmaceuticals company on the JSE, has concluded an agreement with the 100% black-owned Mineworkers Investment Company, (MIC) which will see the fund’s black economic-empowerment (BEE) ownership in Ascendis increase over a three-year period. This would increase... 


Latest News


Latest Videos



Engineering News is a product of Creamer Media.

Other Creamer Media Products include:
Mining Weekly
Research Channel Africa

Read more


We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store


Advertising on Engineering News is an effective way to build and consolidate a company's profile among clients and prospective clients. Email

View options
Free daily email newsletter Register Now
Register Close